An Electronic Data Capture Study to Assess the Long-term Performance of the DePuy PROXIMA™ Hip in Primary Total Hip Replacement
Prospective, International Multi-centre, Uncontrolled, Post Marketing Surveillance Study to Monitor the Long-term Performance of the DePuy PROXIMA™ Hip in Subjects With Indications Suitable for a Primary Total Hip Arthroplasty
Sponsor: DePuy International
Terminated
Study terminated early for business reasons
Other terminated trials from DePuy International
Other Avascular Necrosis trials with similar outcome
A PHASE4 clinical study on Avascular Necrosis and Congenital Hip Dysplasia, this trial is terminated or withdrawn. The trial is conducted by DePuy International and has accumulated 6 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE4
-
Aug 2017 — Jun 2018 [monthly]
Terminated PHASE4
Status: Active Not Recruiting → Terminated
▶ Show 1 earlier version
-
Jan 2017 — Aug 2017 [monthly]
Active Not Recruiting PHASE4
First recorded
Feb 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- DePuy International
For direct contact, visit the study record on ClinicalTrials.gov .